Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 1989Arthritis & Rheumatism

Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three‐year, parallel, randomized, double‐blind study

View Full Paper
Ask AI
Bookmark
Share

Authors

DFDaniel E. FurstRutgers, The State University of New JerseyPCPhilip J. ClementsUniversity of California, Los AngelesSHSteven HillisAmerican University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Furst et al. (1989) studied this question.

synapsesocial.com/papers/6a1740550ef68bc33a8d7452https://doi.org/10.1002/anr.1780320512
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Suppressor cell function and t lymphocyte subpopulations in peripheral blood of patients with progressive systemic sclerosis1983 · 64 citations
  2. 2Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma)1968 · 139 citations
  3. 3Preliminary criteria for the classification of systemic sclerosis (scleroderma)1980 · 4,951 citations